Search results
Showing 1 to 15 of 692 results for innovative
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) aims to streamline patient access to safe, financially sustainable and innovative medicines.
NICE's impact on innovative medicines for childhood conditions
Innovative treatment of leakage and anastomotic insufficiency
Register an interest in this interventional procedure ...
Our medical technologies guidance evaluates new, innovative medical devices and diagnostics.
IPG391/1 Question NICE encourages further research into the use of innovative technologies for the management of severe acute...
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
Health Technology Assessment Innovation Laboratory (HTA Lab)
NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.
Pembrolizumab for advanced melanoma not previously treated with ipilimumab (TA366)
Evidence-based recommendations on pembrolizumab (Keytruda) for treating advanced melanoma in adults who have not had ipilimumab.
Tools for building or evaluating a medtech evidence base with NICE
Evidence-based recommendations on aflibercept (Eylea) for treating visual impairment caused by macular oedema after branch retinal vein occlusion.
Support for industry to engage with NICE during all stages of health technology development
Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic, hormone-relapsed prostate cancer for people in whom chemotherapy is not yet clinically indicated.
Evidence-based recommendations on nintedanib (Vargatef) for treating locally advanced, metastatic or locally recurrent non-small-cell lung cancer in adults.
Register your organisation as a stakeholder with NICE.
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma (TA268)
Evidence-based recommendations on ipilimumab (Yervoy) for previously treated advanced melanoma in adults.